Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth

Pancreatic cancer is an especially deadly form of cancer with a survival rate <2%. Pancreatic cancers respond poorly to existing chemotherapeutic agents and radiation, and progress for the treatment of pancreatic cancer remains elusive. To address this unmet medical need, a better understanding o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fishel, Melissa L., Jiang, Yanlin, Rajeshkumar, N. V., Scandura, Glenda, Sinn, Anthony L., He, Ying, Shen, Changyu, Jones, David R., Pollok, Karen E., Ivan, Mircea, Maitra, Anirban, Kelley, Mark R.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3170439/
https://ncbi.nlm.nih.gov/pubmed/21700832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0107
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares